Standout Papers

Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: phase 1 results from a multicen... 2018 2026 2020 2023 366
  1. Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: phase 1 results from a multicentre, open-label, phase 1/2 study (2018)
    Theodore W. Laetsch, Steven G. DuBois et al. The Lancet Oncology

Immediate Impact

1 from Science/Nature 62 standout
Sub-graph 1 of 23

Citing Papers

Pancreatic cancer
2025 Standout
Glioblastoma: An Update in Pathology, Molecular Mechanisms and Biomarkers
2024 Standout
2 intermediate papers

Works of Mark Reynolds being referenced

Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: phase 1 results from a multicentre, open-label, phase 1/2 study
2018 Standout

Author Peers

Author Last Decade Papers Cites
Mark Reynolds 20 201 180 302 210 23 893
Adam Levy 21 186 63 161 130 42 1.1k
Vivian Y. Chang 6 191 107 129 101 42 966
Cynthia Harris 1 65 114 207 291 16 742
Stephanie C. Melkonian 9 110 145 116 169 41 875
Angela M. Feraco 1 107 46 204 174 21 799
Luis A. Rodríguez 40 161 240 85 113 41 1.1k
M. R. Moore 69 83 279 417 38 1.1k
Thomas E. Goffman 8 75 92 292 283 37 1.1k
Thomas Haas 45 113 228 191 26 1.1k
Dongjing Guo 14 321 129 176 162 33 1.1k

All Works

Loading papers...

Rankless by CCL
2026